Omthera raises $34 million to take omega-3 fatty acid drug into Phase III
15 March 2011
Nancy Faigen
Please Login to read the full article.
15 March 2011
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Omthera seeks 'best in class' status for prescription omega-3 product Epanova
- Phase III data EVOLVE-ing nicely for Omthera's Epanova
- Amarin secures US formulation patent for fish oil pill, fueling more talk on a pharma deal
- Amarin rises on US FDA acceptance of fish oil pill NDA
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
